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Cesarean Scar Pregnancy is a rare type of ectopic pregnancy
where the trophoblasts implant on the niche of the scar. It rep-
resents about 5% of ectopic pregnancy in women with previ-
ous cesarean section. The increases in the rate of cesarean
section together with the increase in awareness of the currentattending obstetricians are behind its increase incidence in
the last two decades (1,2).
No deﬁnite data about the risks or the recurrence of CSP
are found. Studies about the techniques of cesarean scar
closure techniques or inter-pregnancy intervals as risks for
CSP had yield inconclusive results (2).
Early diagnosis by transvaginal ultrasound is the gold
standard way in prevention of the catastrophic hemorrhage.
Early diagnosis allows elective informed choice of treatment.
Although various treatment modalities had been proposed
for treatment of CSP; neither of them had been evidenced
and most obstetricians deal with it according to their
personal preferences or technical capabilities. The most
commonly published treatment is methotrexate intra-lesional
and/or intramuscular. Others report ultrasound guided
978 E.E. Awad et al.manual vacuum aspiration with or without isthmic balloon
insertion. There are many reports about the laparoscopic
management of CSP in experienced hands. Whatever the
treatment choice, it is better than encountered with massive
hemorrhage that ends in most of cases by total hysterectomy
(2,3).
The differential diagnosis of CSP includes early placenta
accreta, cervical abortion (abortion in progress) and cervical
ectopic pregnancy. Unlike CSP; in cervical ectopic pregnancy
there is a healthy (thick) myometrium intervening between
the maternal bladder and the sac together with the ballooned
cervical canal that give the uterus an hour glass appearance.
In cervical abortion there is no peritrophoblastic ﬂow. The
internal os in cervical ectopic and abortion may be opened
or closed but it is always closed in CSP (2).
2. Case report
A 30-year-old female, gravida 3 para 2, was referred by her
attending obstetrician to our center seeking the conﬁrmation
of a pregnancy of abnormal location with vaginal spotting,
and mild abdominal pain for days. She had history of two pre-
vious cesarean sections and had no other signiﬁcant medical or
social history. Serum b-HCG was 2670 mIU/mL.
She was noted to have closed cervix on pelvic examination,
with small amount of dark blood in vaginal vault and no active
vaginal bleeding. All other examinations were unremarkable.
Transvaginal ultrasound showed Empty uterine cavity, pulsat-
ing 7 week embryo out-pouches from the uterus at the site of
the scar. The overlying myometrium is too thin (indistinct)
and vascular. The internal cervical os is closed. Empty cervical
canal and no intrauterine pregnancy or adnexal masses. This
was considered to be cesarean scar ectopic pregnancy or earlyFig. 1 The embryo out-pouches the scar on 2D US with vascula
7 weeks(b), closed internal cervical os below the pregnancy with empty
multi-planner reconstruction (MPR) mode shows that the embryo outs
uterus shows the out-pouching of the CS pregnancy at the site of the sca
thinned myometrium overlying the pregnancy (f).placenta accreta. (Fig. 1). She was managed using intramuscu-
lar methotrexate (50 mg). After about two weeks she devel-
oped accidentally massive vaginal bleeding that warrants
laparotomy that conﬁrmed the cesarean ectopic pregnancy
(Fig. 2) where excision of the gestational sac was done and
trimming of the surrounding myometrium and enclosure in 2
layers. Her symptoms subsided and b-HCG was noted to be
trending down adequately. She was discharged home and her
follow-up ultrasound revealed no residual mass at the scar
and a b-HCG level less than 5 mIU/mL within 2 weeks of
her treatment.
3. Discussion
Cesarean scar ectopic pregnancy is a rare lethal variant of ecto-
pic pregnancy, where gestational sac implants at the previous
uterine scar (4,5). Cesarean scar ectopic pregnancy is often
misdiagnosed as incomplete abortion and patients mistakenly
undergo curettage leading to life threatening hemorrhage.
Diagnosis of cesarean scar pregnancy requires a high degree
of suspicion, especially when no intrauterine gestational sac
can be identiﬁed and a pregnancy of unknown location is sus-
pected. Differential diagnosis of cesarean scar ectopic
pregnancy includes cervical pregnancy, early placenta accreta
and incomplete abortion. Timor et al. concluded in their
review that cesarean scar ectopic pregnancy and early
pregnancy placenta accreta are the consequences of increasing
rate of cesarean deliveries (6). They explored the similarities in
symptomatology, diagnosis and treatment of these two
conditions. Cesarean scar pregnancy can be diagnosed with
transvaginal ultrasound which can identify a gestational sac
or mass located in the lower uterine segment, within the cesar-
ean scar. MRI can accurately detect the exact location ofr thinned myometrium at scar site (a), viable pregnancy nearly
cervical canal (c), 3D ultrasound imaging of the uterus using the
ide the empty endometrial cavity (d), 3D ultrasound imaging of the
r (e), 3D power Doppler ultrasound conﬁrms the vascularity of the
Fig. 2 Operative view showing abnormal pregnancy bulging out.
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unique treatment modality available to effectively terminate
this pregnancy. However, a combination of different tech-
niques including UAE and intragestational Methotrexate
(7,8); intramuscular and intragestational Methotrexate (9);
hysteroscopic or laparoscopic resection after uterine artery
embolization or curettage after intragestational methotrexate
or UAE has all been attempted with varied success rates by dif-
ferent authors. Shao et al. reported shorter curettage duration
after local methotrexate injection and shorter hysterectomy
duration with lowest operative blood loss as well as shorter
length of hospital stay after UAE (10). They also noted short-
est time in b-HCG level returning to normal in patients that
underwent laparoscopic or hysteroscopic resection after a local
methotrexate injection or UAE (10). Curettage alone may lead
to excessive blood loss, thus necessitating hysterectomy (11).
Therefore, a combination of different modalities is preferred
by most authors. Shen et al. found bilateral uterine artery
chemoembolization and local methotrexate injection to be a
safe and effective treatment for cesarean scar pregnancy, with
minimal morbidity (7). Wang et al. described a newer
transvaginal approach in removal of ectopic tissue from the
cesarean scar via transvaginal hysterotomy (12,13). They
reported no signiﬁcant complications, a faster time to return
to normal menstrual cycles and a rapid decline of b-HCG to
normal than reported with the current techniques (13). Theyalso combined methotrexate injection with transvaginal hys-
terotomy for improved results (12). This technique needs to
be further evaluated for its safety and efﬁcacy.
Early diagnosis and early treatment of cesarean scar ectopic
pregnancy are essential to prevent maternal morbidity and
mortality. Early diagnosis is possible by early clinical suspicion
on behalf of the physician in a patient with pregnancy of
unknown location and an early recognition of sonographic
ﬁndings (4). Several medical and surgical modalities are avail-
able for the treatment of cesarean scar pregnancy, but most
authors have reported the combination of 2–3 different tech-
niques more useful than any method used alone. Especially,
curettage alone without a prior uterine artery embolization
or local methotrexate injection may lead to life threatening
bleeding (8). Also, a close follow-up with serial quantitative
b-HCG levels is needed until level falls to <5 mIUs/mL.
Modern obstetricians need to be aware of the increasing inci-
dence of this condition due to increase in cesarean section rates
(4) and evaluate patients at risk with ultrasound, before under-
taking curettage which can lead to hemorrhage and loss of
fertility.
4. Conclusions
Whether early placenta accreta or cesarean ectopic pregnancy,
both have similar diagnoses and management that should be
kept in mind and suspected on routine ﬁrst trimester ultra-
sound and referred to experienced sonographer if suspected
or not sure of diagnoses.
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